Evidence map›Paper›PMID 39330351›Full record

ArticleJournal of cardiovascular development and disease2024

Septal Myectomy in Patients with Hypertrophic Cardiomyopathy and Nonclassical Anderson-Fabry Disease.

Alexandr Gurschenkov, Sofiya Andreeva, Vadim Zaitsev, Pavel Khazov, Gleb Ischmukhametov, Alexandra Kozyreva, Polina Sokolnikova, Olga Moiseeva, Anna Kostareva, Mikhail Gordeev

Abstract readCase Reports
In one paragraph

Article in Journal of cardiovascular development and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexandr GurschenkovInstitute of Cardiovascular Science, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.ORCID 0000-0001-8494-0646
Sofiya AndreevaWorld-Class Research Centre for Personalized Medicine, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Vadim ZaitsevInstitute of Cardiovascular Science, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Pavel KhazovInstitute of Cardiovascular Science, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Gleb IschmukhametovInstitute of Cardiovascular Science, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Alexandra KozyrevaWorld-Class Research Centre for Personalized Medicine, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Polina SokolnikovaWorld-Class Research Centre for Personalized Medicine, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Olga MoiseevaInstitute of Cardiovascular Science, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
Anna KostarevaWorld-Class Research Centre for Personalized Medicine, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.ORCID 0000-0002-9349-6257
Mikhail GordeevInstitute of Cardiovascular Science, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.

Funding

Ministry of Science and Higher Education of Russian Federation Agreement No. 075-15-2022-301
6 · The paper itself

Abstract

Anderson-Fabry disease (AFD) results from decreased enzyme activity of lysosomal enzymes and intralysosomal storage of nonhydrolyzed forms. Cardiovascular complications, mainly in the form of HCM, contribute substantially to AFD patient mortality. Here, we report three new cases of obstructive HCM (HOCM) in nonclassical presentations of AFD and isolated cardiac involvement. In all three cases, the diagnosis of AFD was made postoperatively by routine genetic and morphological testing. Together with previously published cases, this report illustrates the potential safety and beneficial effect of septal surgical myectomy in patients with AFD-HOCM, as well as underlines the need for more thorough screening for clinical signs of AFD-associated cardiomyopathy and

Indexed as

Anderson–Fabry diseaseGLAhypertrophic cardiomyopathymyectomyobstructive

Identifiers

PMID39330351
PMCPMC11432192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.